`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`MEDTRONIC, INC., AND MEDTRONIC VASCULAR, INC.,
`
`Petitioner,
`
`v.
`
`TELEFLEX INNOVATIONS S.À.R.L.,
`
`Patent Owner.
`
`Case IPR2020-01341
`Case IPR2020-01343
`U.S. Patent No. 8,142,413
`U.S. Patent No. RE 46,116
`
`PETITIONER’S MOTION FOR ADDITIONAL DISCOVERY:
`MOTION FOR LEAVE TO SUBPOENA NON-PARTY WITNESSES
`(FILED WITH BOARD AUTHORIZATION)
`
`REDACTED
`
`
`
`Pursuant to 35 U.S.C. § 316(a)(5) and 37 C.F.R. § 42.51(b)(2), Petitioner
`
`moves for leave to serve subpoenas for testimony on three non-party witnesses:
`
`Jim Kauphusman, a former VSI engineer; Katie Mytty, a former VSI technician;
`
`and Jeff Welch, a named inventor on the patents-in-suit and former VSI employee.
`
`As the Board knows, conception and reduction to practice is a critical,
`
`dispositive issue in these proceedings.1 The conception and reduction to practice
`
`record will dictate whether one of Petitioner’s references, Itou, is prior art. The
`
`limited record in these proceedings shows that Kauphusman, Mytty, and Welch
`
`have unique, first-hand knowledge of whether VSI reduced the claimed inventions
`
`to practice via assembly and testing of GuideLiner RX prototypes. Yet we have not
`
`heard from these individuals. By all accounts, they are the ones who would have
`
`led and performed the engineering and prototype work required to reduce to
`
`practice. Petitioner seeks their testimony because it has evidence that these
`
`
`1 To the extent Patent Owner argues that the Board already decided conception and
`
`reduction to practice in the related set of IPRs, Petitioner submits that the patents at
`
`issue here recite method claim and, thus, change the character of the reduction-to-
`
`practice analysis. Patent Owner will need to show that VSI performed the claimed
`
`processes, making the details of the testing and, as a result, the individuals who
`
`purportedly performed that testing, all the more significant.
`
`1
`
`REDACTED
`
`
`
`individuals did not perform RX prototype work during the relevant period, before
`
`Itou. Kauphusman’s and Mytty’s laboratory notebooks show that they worked on
`
`only OTW (prior art)—not RX (patented)—prototypes during the relevant period.
`
`Welch’s notebook does not mention GuideLiner until years after the Itou reference.
`
`Root tries to offer an explanation for the conspicuous discrepancy in the
`
`record. See Ex-2118 ¶ 94 (arguing that the Kauphusman and Mytty notebooks
`
`“show VSI’s testing of GuideLiner OTW in preparation for submitting our
`
`application to the FDA for regulatory clearance, not for purposes of confirming the
`
`device would work”). But the record contains no evidence that VSI sought
`
`regulatory clearance for or commercialized its OTW device. A more plausible
`
`explanation for the absence of RX notebook entries (based not on inventor say-so
`
`but on the evidentiary record) is that the key engineering witnesses did not
`
`assemble and test RX prototypes until after Itou. Petitioner moves the Board for
`
`leave to get that explanation into the record. This case turns on whether VSI
`
`performed the requisite engineering work; the requested testimony is crucial.
`
`The Garmin factors favor granting additional discovery and determining,
`
`from the key sources, whether Patent Owner can swear behind Itou.
`
`I.
`
`Legal Standard
`
`“Under the Leahy-Smith America Invents Act, discovery is available for . . .
`
`‘what is otherwise necessary in the interest of justice.’” Garmin Int’l, Inc. v.
`
`2
`
`REDACTED
`
`
`
`Cuozzo Speed Techs. LLC, IPR2021-00001, Paper 26 at 5 (PTAB Mar. 5, 2013)
`
`(precedential) (quoting 35 U.S.C. § 316(a)(5)); see also 37 C.F.R. § 42.51(b)(2)
`
`(“The moving party must show that such additional discovery is in the interests of
`
`justice . . . .”).
`
`The Board’s precedential Garmin decision identifies five factors “important”
`
`to deciding whether to allow additional discovery: (1) more than a possibility and
`
`mere allegation; (2) litigation positions and underlying basis; (3) ability to generate
`
`equivalent information by other means; (4) easily understandable instructions; and
`
`(5) requests not overly burdensome to answer. Garmin, Paper 26 at 6.
`
`II.
`
`
`
`First Garmin factor: The record demonstrates more than a possibility or
`mere allegation that Kauphusman, Mytty, and Welch will provide
`useful testimony that will allow Petitioner to rebut Patent Owner’s
`reduction-to-practice arguments.
`
`Under the first Garmin factor, “[t]he party requesting discovery should
`
`already be in possession of evidence tending to show beyond speculation that in
`
`fact something useful will be uncovered.” Garmin, Paper 26 at 6. “Useful” means
`
`“favorable in substantive value to a contention of the party moving for discovery.”
`
`Id. at 7. Here, laboratory notebooks and other VSI engineering documents,
`
`declarations, and deposition testimony more than suggest that Kauphusman, Mytty,
`
`and Welch will provide useful, favorable testimony.
`
`Unlike the witnesses that Patent Owner offers, Kauphusman, Mytty, and
`
`Welch led RX engineering efforts and assembled and tested GuideLiner
`
`3
`
`REDACTED
`
`
`
`prototypes. But their laboratory notebooks reveal that at most, they performed only
`
`OTW work during the relevant period. Thus, Petitioner has evidence tending to
`
`show beyond speculation that Kauphusman, Mytty, and Welch will testify they did
`
`not build or test RX prototypes during the relevant period. That testimony will
`
`undermine Patent Owner’s reduction-to-practice narrative and support Petitioner’s
`
`contention that VSI did not perform critical prototype work sufficient to swear
`
`behind Itou.
`
`VSI engineering documents, declarations, and deposition testimony confirm
`
`that Kauphusman led VSI’s RX engineering and prototype work. Inventor Gregg
`
`Sutton testified that Kauphusman was “the primary engineer working on the rapid
`
`exchange version” in 2005. Ex-1757, 33:11-15; see also Ex-1794, 47:23-48:8
`
`(Sutton identifying Kauphusman as “
`
`
`
`
`
`. Sutton could not remember specifics, but he was “sure” that he met
`
`with Kauphusman “to discuss development of the GuideLiner rapid exchange
`
`device.” Ex-1757, 34:7-20. Sutton and Kauphusman discussed “problem areas”—
`
`including “making the—what we called at the time the backbone”—and other
`
`engineering issues, including “what materials to use, where to get them, how to
`
`make them, [and] how to design them.” Id., 34:21-35:15. Kauphusman—and only
`
`Kauphusman, as far as Petitioner can tell—led RX engineering efforts during the
`
`4
`
`REDACTED
`
`
`
`relevant period. See also id., 36:3-8, 71:25-72:14. Indeed, Kauphusman’s name
`
`appears on the component parts engineering drawings that Patent Owner cites to
`
`argue that VSI assembled RX prototypes in mid-2005. See Ex-2122 ¶¶ 14-18
`
`(citing Ex-2089, Ex-2092, Ex-2113, and Ex-2114 and explaining that Kauphusman
`
`drew the engineering drawings for the parts orders).
`
`Kauphusman led critical engineering and prototype work, but the evidence
`
`more than suggests that Kauphusman did not perform that work during the
`
`relevant period. Kauphusman’s laboratory notebook shows that he worked on only
`
`OTW prototypes in 2005 and 2006. Ex-1760, 86-87, 91-93 (300-centimeter, 0.014”
`
`guidewire indicating OTW, not RX, prototype). And a VSI “Special Work Order
`
`Number Assignment Log” shows that in December 2005, VSI cancelled and could
`
`not complete GuideLiner design verification testing, due to a
`
`
`
`Ex-1768, 14. “Jim K.”—Kauphusman—requested that work and then cancelled it.
`
`This evidence more than suggests that he will have information regarding why VSI
`
`could not complete that work.
`
`Mytty worked alongside Kauphusman and should provide similar testimony.
`
`Sutton identified Mytty as one of the “main individuals working with Mr.
`
`Kauphusman on the RX version.” Ex-1757, 33:23-34:6. Yet Mytty’s two
`
`laboratory notebooks indicate that she worked on only OTW prototypes in 2005
`
`and 2006. Ex-1761, 107-13; Ex-1774, 10-12. Therefore, Petitioner possesses
`
`5
`
`REDACTED
`
`
`
`evidence that tends to show beyond speculation that Mytty will provide useful,
`
`favorable testimony: that VSI did not complete critical RX prototype work or
`
`reduce its inventions to practice when its less-knowledgeable witnesses claim.
`
`Patent Owner contends that Welch built and tested relevant prototypes, too.
`
`See Ex-2118 ¶ 15 (Root declaration stating, “I recall Mr. Sutton and Mr. Welch
`
`(another of the named inventors) leading the efforts to make the first [RX]
`
`prototype”); Ex-1756, 62:3-63:20 (Erb testifying that Welch “was heavily involved
`
`in the testing”), 67:20-69:11 (Erb testifying that “it probably would have been Jeff
`
`Welch” performing material prototype testing). Yet, like Kauphusman and Mytty,
`
`Welch’s notebook tells a different story:
`
`
`
` Ex-1758, 12-14. Thus, like Kauphusman and Mytty,
`
`Petitioner possesses evidence that tends to show beyond speculation that Welch
`
`will provide useful, favorable testimony: that VSI did not complete critical RX
`
`prototype work or reduce its inventions to practice when its less-knowledgeable
`
`witnesses claim.
`
`To Petitioner’s knowledge, the Board has not had the opportunity to address
`
`additional discovery related to rebutting reduction-to-practice arguments. But the
`
`substantive value of the testimony that Petitioner seeks is not unlike the value of
`
`additional discovery that the Board has allowed. For example, the Board
`
`recognized that evidence “relevant to determining whether [an asserted reference]
`
`6
`
`REDACTED
`
`
`
`qualifies as prior art” is useful. Canon Inc. v. Avigilon Fortress Corp., IPR2019-
`
`00311, 2019 WL 4239623, at *2 (PTAB Sept. 6, 2019). Here, Petitioner’s ability to
`
`rebut Patent Owner’s reduction-to-practice arguments will determine whether Itou
`
`is prior art. Existing evidence more than suggests that Kauphusman, Mytty, and
`
`Welch will testify that they do not remember working on RX prototypes in 2005-
`
`2006 and that, if they had, they would have written it down in their notebooks. That
`
`testimony will help Petitioner argue that Patent Owner cannot swear-behind Itou.
`
`The first Garmin factor weighs in favor of allowing the depositions.
`
`III. Second Garmin factor: Petitioner does not seek any information
`regarding Patent Owner’s litigation positions.
`
`
`
`“Asking for the other party’s litigation positions and the underlying basis for
`
`those positions is not necessary in the interest of justice.” Garmin, Paper 26 at 6.
`
`Petitioner does not seek any information regarding Patent Owner’s litigation
`
`positions. The second Garmin factor weighs in favor of allowing the depositions.
`
`IV. Third Garmin factor: Petitioner cannot otherwise obtain the
`information it seeks, including from witnesses that Patent Owner has
`made available.
`
`
`
`“Information a party can reasonably figure out or assemble without a
`
`discovery request would not be in the interest of justice to have produced by the
`
`other party.” Garmin, Paper 26 at 6. The information that Petitioner seeks is non-
`
`7
`
`REDACTED
`
`
`
`public and in only Kauphusman’s, Mytty’s, and Welch’s possession.2 Indeed,
`
`deposition testimony confirms that the witnesses that Patent Owner has chosen to
`
`make available cannot provide the information. Sutton testified that he did not
`
`keep notes tracking GuideLiner work; he relied on Kauphusman and Mytty to keep
`
`notes, testifying that “[m]ost projects’ specific notes are kept by the engineers’
`
`technicians.” Ex-1757, 35:16-36:2. Root indicated that he “[doesn’t] know
`
`specifically who build all the prototypes,” but “[t]he people working on it were
`
`Gregg Sutton, Jeff Welch, maybe Jim Kauphusman,” with “Steve Erb making
`
`components” and “maybe Katie Mytty doing some of the testing.” Ex-1762, 82:19-
`
`25. Sutton confirmed that he only oversaw and did not perform GuideLiner
`
`prototype work. See, e.g., Ex-1757, 33:6-10 (“I wasn’t involved directly with either
`
`of these [working on OTW or RX], other than oversight and direction . . . .”). Erb’s
`
`role was limited to making early components. So according to Patent Owner’s
`
`witnesses, only Kauphusman, Mytty, and Welch were working on relevant
`
`prototypes. Thus, only they can provide testimony likely to undercut Patent
`
`Owner’s reduction-to-practice narrative. Rather than offer the key VSI witnesses,
`
`Patent Owner offers less-knowledgeable witnesses to corroborate its inventors.
`
`
`2 None of these witnesses currently work for Teleflex. And to Petitioner’s
`
`knowledge, none have worked for VSI / Teleflex for many years.
`
`8
`
`REDACTED
`
`
`
`The third Garmin factor weighs in favor of allowing the depositions.
`
`V. The fourth Garmin factor does not apply and, thus, does not weigh
`against the requested discovery.
`
`The fourth Garmin factor considers instructions that accompany written
`
`
`
`discovery. See, e.g., Garmin, Paper 26 at 14 (considering interrogatory and
`
`document request instructions). Here, Petitioner does not seek leave to serve
`
`written discovery. Petitioner will serve only standard subpoenas for testimony.
`
`Kauphusman, Mytty, and Welch will be responsible for testifying truthfully and
`
`completely based on their personal knowledge. The fourth Garmin factor cannot
`
`weigh against allowing the depositions.
`
`VI. Fifth Garmin factor: The depositions will not be burdensome, and
`Petitioner is willing to limit each deposition to four hours.
`
`Under the fifth Garmin factor, the Board considers “financial burden, burden
`
`
`
`on human resources, and burden on meeting the time schedule of Inter Partes
`
`Review.” Garmin, Paper 26 at 6. “Requests should be sensible and responsibly
`
`tailored according to a genuine need.” Id.
`
`The requested depositions will not be burdensome. As mentioned,
`
`Kauphusman, Mytty, and Welch will be responsible for testifying truthfully and
`
`completely based on their personal knowledge. The depositions will impose no
`
`financial burden on the deponents, as Petitioner will travel to the deponents or
`
`provide for remote depositions. Petitioner anticipates that the Board will have the
`
`9
`
`REDACTED
`
`
`
`opportunity to rule on this motion in time for Petitioner to secure these depositions,
`
`if allowed, before it submits its Reply, thereby meeting the schedule for this
`
`proceeding.
`
`Petitioner seeks targeted information from these witnesses related to a
`
`particular time period and a particular project. Thus, Petitioner does not anticipate
`
`that it will need more than four hours for each of the depositions that it seeks.
`
`Further, if the Board does not believe that all three depositions are in the interests
`
`of justice, Petitioner would rank them in the order of Kauphusman, Mytty, and
`
`then Welch. Petitioner asks that Board grant leave to depose as least Kauphusman,
`
`as the evidence suggests that he will have the most useful information.
`
`The fifth Garmin factor weighs in favor of allowing the depositions.
`
`*
`
`*
`
`*
`
`Each Garmin factor weighs in favor of allowing these narrow depositions or
`
`is neutral. Petitioner requests that the Board grant its motion for additional
`
`discovery.
`
`
`
`Dated: July 1, 2021
`
`Respectfully submitted,
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Robins Kaplan LLP
`2800 LaSalle Plaza
`800 LaSalle Avenue
`
`10
`
`REDACTED
`
`
`
`Minneapolis, MN 55402
`Attorney for Petitioner
`
`
`
`
`
`
`
`11
`
`REDACTED
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that on July 1, 2021, a copy of PETITIONER’S MOTION FOR
`
`ADDITIONAL DISCOVERY: MOTION FOR LEAVE TO SUBPOENA NON-
`
`PARTY WITNESSES (FILED WITH BOARD AUTHORIZATION) and all
`
`supporting exhibits were served in their entirety by electronic mail on Patent
`
`Owner’s counsel at the following addresses indicated in Patent Owner’s
`
`Mandatory Notices:
`
`J. Derek Vandenburgh, Reg. No. 32,179
`dvandenburgh@carlsoncaspers.com
`
`Dennis C. Bremer, Reg. No. 40,528
`dbremer@carlsoncaspers.com
`
`Joseph W. Winkels
`jwinkels@carlsoncaspers.com
`
`Peter M. Kohlhepp
`pkohlhepp@carlsoncaspers.com
`
`Alexander S. Rinn
`pkohlhepp@carlsoncaspers.com
`
`Megan E. Christner, Reg. No. 78,979
`mchristner@carlsoncaspers.com
`
`Respectfully submitted,
`
`/Cyrus A. Morton/
`Cyrus A. Morton
`Reg. No. 44,954
`Attorney for Petitioner
`
`12
`
`
`
`Dated: July 1, 2021
`
`
`
`REDACTED
`
`